State Street's 6.1% passive stake is a routine institutional holding. Monitor for any future 13D conversion or significant share changes, but no near-term activist or control implications are indicated.
ARQT drugs
ARQT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $27.39entry
- T+1 · 6d ago +3.63%α +2.31% · $28.38
- T+4 · todayOpen
- T+5 · in 5h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
State Street Corporation filed a Schedule 13G disclosing a 6.1% passive stake in Arcutis Biotherapeutics as of September 30, 2026, representing 7,718,628 shares. This is a routine passive ownership update with no change in investment intent, and the filing does not provide prior-period share counts for comparison.
Key Financial Metrics
Key Facts
- State Street Corporation disclosed a 6.1% passive beneficial ownership stake in Arcutis Biotherapeutics as of September 30, 2026.
- The stake comprises 7,718,628 shares of common stock.
- State Street certifies the shares were acquired and held in the ordinary course of business, not for changing or influencing control.
- The filing is an initial Schedule 13G by State Street; no prior 13G from this filer is in the cross-filing context.
Financial Impact
6.1% passive stake valued at approximately $195M based on $3.2B market cap at analysis time.
Risk Factors
- No material risks identified from this passive filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000615 |
| Document: 0000093751-26-000615-index.html | 0000093751-26-000615 |
| Document: 0000093751-26-000615.txt | 0000093751-26-000615 |
Track record
34 reports on ARQT
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $27.39 Now $27.15 −0.86% settles Feb 8
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
- Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers